HOXA4
Basic information
Region (hg38): 7:27128507-27130780
Previous symbols: [ "HOX1D", "HOX1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXA4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 36 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 37 | 7 | 10 |
Variants in HOXA4
This is a list of pathogenic ClinVar variants found in the HOXA4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-27128893-C-G | Benign (Nov 12, 2018) | |||
7-27128971-A-G | Benign (Nov 12, 2018) | |||
7-27129100-C-T | Benign (Nov 12, 2018) | |||
7-27129263-G-T | not specified | Uncertain significance (Jul 06, 2021) | ||
7-27129268-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
7-27129269-G-A | not specified | Uncertain significance (May 01, 2022) | ||
7-27129277-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
7-27129292-G-A | not specified | Uncertain significance (May 21, 2024) | ||
7-27129301-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
7-27129308-G-T | not specified | Uncertain significance (Feb 06, 2023) | ||
7-27129343-C-G | not specified | Uncertain significance (Jun 29, 2023) | ||
7-27129352-G-A | not specified | Uncertain significance (Oct 28, 2024) | ||
7-27129365-T-C | not specified | Uncertain significance (Jan 03, 2022) | ||
7-27129388-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
7-27129415-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
7-27129418-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
7-27129461-G-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
7-27129474-T-G | Benign (Jun 09, 2021) | |||
7-27129478-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
7-27129518-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
7-27129536-A-G | not specified | Uncertain significance (Dec 21, 2023) | ||
7-27129538-C-A | not specified | Uncertain significance (Jun 22, 2021) | ||
7-27129538-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
7-27129544-G-C | not specified | Uncertain significance (Jan 03, 2024) | ||
7-27129750-T-C | Benign (Jun 19, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HOXA4 | protein_coding | protein_coding | ENST00000360046 | 2 | 2293 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000860 | 0.329 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.332 | 142 | 131 | 1.08 | 0.00000737 | 1952 |
Missense in Polyphen | 48 | 39.879 | 1.2037 | 440 | ||
Synonymous | -0.272 | 61 | 58.4 | 1.05 | 0.00000322 | 663 |
Loss of Function | 0.193 | 8 | 8.61 | 0.929 | 5.05e-7 | 101 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000117 | 0.000117 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000712 | 0.0000703 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to sites in the 5'-flanking sequence of its coding region with various affinities. The consensus sequences of the high and low affinity binding sites are 5'-TAATGA[CG]-3' and 5'-CTAATTTT- 3'.;
- Pathway
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.439
- hipred
- N
- hipred_score
- 0.354
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.572
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hoxa4
- Phenotype
- skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- skeletal system development;anatomical structure morphogenesis;anterior/posterior pattern specification;positive regulation of transcription by RNA polymerase II;embryonic skeletal system morphogenesis
- Cellular component
- nucleus;nuclear body
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;activating transcription factor binding